Bicycle Therapeutics (BCYC) PT Raised to $35 at Roth Capital, Following Earnings

May 6, 2021 12:05 PM EDT
Get Alerts BCYC Hot Sheet
Price: $29.69 -0.03%

Rating Summary:
    9 Buy, 0 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 15 | Down: 17 | New: 13
Trade Now! 
Join SI Premium – FREE

Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.

Roth Capital analyst Tony Butler raised the price target on Bicycle Therapeutics (NASDAQ: BCYC) to $35.00 (from $30.00) while maintaining a Buy rating.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst PT Change

Related Entities

Roth Capital, Earnings